124 related articles for article (PubMed ID: 445443)
1. Role of adrenals and estrogen in regression of mammary tumors during postpartum lactation in the rat.
Aylsworth CF; Hodson CA; Berg G; Kledzik G; Meites J
Cancer Res; 1979 Jul; 39(7 Pt 1):2436-9. PubMed ID: 445443
[TBL] [Abstract][Full Text] [Related]
2. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
3. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
[TBL] [Abstract][Full Text] [Related]
4. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
Rose DP; Gottardis M
Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
[TBL] [Abstract][Full Text] [Related]
5. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
6. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of carcinogen-induced mammary tumor growth in rats by adrenalectomy.
Chen HJ; Bradley CJ; Meites J
Cancer Res; 1976 Apr; 36(4):1414-7. PubMed ID: 816463
[TBL] [Abstract][Full Text] [Related]
8. Hyperthyroidism and production of precocious involution in the mammary glands of lactating rats.
Varas SM; Muñoz EM; Hapon MB; Aguilera Merlo CI; Giménez MS; Jahn GA
Reproduction; 2002 Nov; 124(5):691-702. PubMed ID: 12417008
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
Leung BS; Sasaki GH; Leung JS
Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
[TBL] [Abstract][Full Text] [Related]
10. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
11. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
Sylvester PW; Aylsworth CF; Meites J
Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
[TBL] [Abstract][Full Text] [Related]
12. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammary tumor growth by dexamethasone in rats in the presence of high serum prolactin levels.
Aylsworth CF; Sylvester PW; Leung FC; Meites J
Cancer Res; 1980 Jun; 40(6):1863-6. PubMed ID: 7371016
[TBL] [Abstract][Full Text] [Related]
14. Modification of the effect of a gonadoliberin analog on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by hormone replacement.
Rose DP; Pruitt B
Cancer Res; 1979 Oct; 39(10):3968-70. PubMed ID: 113083
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
17. Hormonal control of growth and progression in tumors of Nb rats and a theory of action.
Noble RL
Cancer Res; 1977 Jan; 37(1):82-94. PubMed ID: 830424
[TBL] [Abstract][Full Text] [Related]
18. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
[TBL] [Abstract][Full Text] [Related]
19. Adrenal regulation of mammary tumorigenesis in female Sprague-Dawley rats: incidence, latency, and yield of mammary tumors.
Carter JH; Carter HW; Meade J
Cancer Res; 1988 Jul; 48(13):3801-7. PubMed ID: 3132320
[TBL] [Abstract][Full Text] [Related]
20. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
